The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The bleeding disorder testing market has seen substantial growth recently, with its size increasing from $13.92 billion in 2023 to $14.99 billion in 2024, reflecting a compound annual growth rate (CAGR) of 7.7%. This growth is attributed to factors such as the rising prevalence of bleeding disorders, increased investment in research and development, the proliferation of specialized clinics, higher demand for early diagnosis, and a growing number of clinical trials. The market is projected to continue expanding, reaching $20.40 billion by 2028 at a CAGR of 8.0%. This forecast growth is driven by factors including the increasing prevalence of hemophilia, rising awareness of bleeding disorder symptoms, growing investment in diagnostic research, higher global healthcare spending, and the increasing prevalence of rare bleeding disorders. Major trends in the forecast period include technological advancements, the integration of artificial intelligence, personalized medicine, telemedicine services, and home-based testing kits.

The increasing number of clinical trials is expected to propel the growth of the bleeding disorder testing market going forward. Clinical trials are research studies assessing the safety and efficacy of new medical treatments, therapies, medicines, or technologies in humans. The increase in clinical trials is attributed to advancements in medical research, growing investment in healthcare innovation, and rising demand for new treatments. Bleeding disorder testing is used in these trials to evaluate the efficacy and safety of new treatments for bleeding disorders, assess management of clotting abnormalities, and monitor patient responses. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, around 477,228 clinical trials were registered at the end of 2023, an increase from 437,507 in 2022. Therefore, the increasing number of clinical trials is driving the growth of the bleeding disorder testing market.

Get A Free Sample On The Bleeding Disorder Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18263&type=smp

What Are The Key Trends That Influence Bleeding Disorder Testing Market Share Analysis?
Major companies operating in the bleeding disorder testing market are focused on developing innovative products, such as gene therapy for Hemophilia B, to provide long-term solutions, cure genetic bleeding disorders, enhance treatment outcomes, and expand their market reach. Hemophilia B is a type of bleeding disorder. It is characterized by a deficiency of clotting factor IX, which is essential for proper blood coagulation. Gene therapy for Hemophilia B is an emerging treatment aimed at providing a long-term solution by addressing the underlying genetic defect responsible for the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, and the European Commission approved conditional marketing authorization (CMA) for HEMGENIX, the first and only one-time gene therapy for treating severe and moderately severe hemophilia B. This one-time treatment aims to provide long-lasting efficacy, reducing or eliminating the need for regular factor replacement therapy. HEMGENIX is notable for its innovative approach to gene therapy, offering a transformative option for patients with hemophilia B and potentially changing the standard of care in the field.

How Is The Global Bleeding Disorder Testing Market Segmented?
1) By Product Type: Reagents And Consumables; Instruments
2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users

Read The Full Bleeding Disorder Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

The Bleeding Disorder Testing Global Market Report 2024 provides an overview of the bleeding disorder testing market for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The bleeding disorder testing market forecast analyzes bleeding disorder testing market size, bleeding disorder testing market share, leading competitor and their market positions.

The Table Of Content For The Bleeding Disorder Testing Market Include:

Explore Similar Reports From The Business Research Company:
Bleeding Disorders Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Blood And Blood Components Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Capsule Endoscopy System Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/capsule-endoscopy-system-global-market-report

Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: